Changes in the hypothalamic pituitary adrenocortical (HPA) system and its modulation by the cortisone-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), corticosteroids and their receptors are suggested to mediate the adverse effects of anxiety disorders on CHD [17,18]. The gene discussed is POMC; the disease is coronary artery disorder.